HomeCompareSPNE vs YUM

SPNE vs YUM: Dividend Comparison 2026

SPNE yields 20.96% · YUM yields 1.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 YUM wins by $30.5K in total portfolio value· pulled ahead in Year 10
10 years
SPNE
SPNE
● Live price
20.96%
Share price
$9.54
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$77.5K
Annual income
$7,459.80
Full SPNE calculator →
YUM
YUM
● Live price
1.86%
Share price
$154.59
Annual div
$2.88
5Y div CAGR
51.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$107.9K
Annual income
$40,443.52
Full YUM calculator →

Portfolio growth — SPNE vs YUM

📍 YUM pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSPNEYUM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SPNE + YUM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SPNE pays
YUM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SPNE
Annual income on $10K today (after 15% tax)
$1,781.97/yr
After 10yr DRIP, annual income (after tax)
$6,340.83/yr
YUM
Annual income on $10K today (after 15% tax)
$158.35/yr
After 10yr DRIP, annual income (after tax)
$34,376.99/yr
At 15% tax rate, YUM beats the other by $28,036.16/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SPNE + YUM for your $10,000?

SPNE: 50%YUM: 50%
100% YUM50/50100% SPNE
Portfolio after 10yr
$92.7K
Annual income
$23,951.66/yr
Blended yield
25.84%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on YUM right now

SPNE
Analyst Ratings
9
Buy
1
Hold
Consensus: Buy
Price Target
$9.38
-1.7% upside vs current
Range: $6.75 — $12.00
YUM
Analyst Ratings
18
Buy
30
Hold
3
Sell
Consensus: Hold
Price Target
$173.15
+12.0% upside vs current
Range: $158.00 — $190.00
Altman Z
2.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SPNE buys
0
YUM buys
0
No recent congressional trades found for SPNE or YUM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSPNEYUM
Forward yield20.96%1.86%
Annual dividend / share$2.00$2.88
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.4%
Portfolio after 10y$77.5K$107.9K
Annual income after 10y$7,459.80$40,443.52
Total dividends collected$45.1K$81.2K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusBuyHold
Analyst price target$9.38$173.15

Year-by-year: SPNE vs YUM ($10,000, DRIP)

YearSPNE PortfolioSPNE Income/yrYUM PortfolioYUM Income/yrGap
1$12,796$2,096.44$10,982$282.06+$1.8KSPNE
2$16,199$2,507.19$12,189$438.29+$4.0KSPNE
3$20,300$2,966.28$13,731$688.32+$6.6KSPNE
4$25,194$3,473.91$15,789$1,097.12+$9.4KSPNE
5$30,988$4,029.51$18,679$1,785.08+$12.3KSPNE
6$37,789$4,631.81$22,975$2,988.18+$14.8KSPNE
7$45,713$5,278.85$29,784$5,200.49+$15.9KSPNE
8$54,881$5,968.03$41,408$9,539.16+$13.5KSPNE
9$65,418$6,696.22$63,071$18,765.27+$2.3KSPNE
10← crossover$77,457$7,459.80$107,930$40,443.52$30.5KYUM

SPNE vs YUM: Complete Analysis 2026

SPNEStock

SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. It offers orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. The company's orthobiologics products include demineralized bone matrix (DBM), collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to improve bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures. It also offers orthobiologics products in various forms, such as fibers, putties, pastes, strips, and DBM. In addition, the company offers implant products for spinal decompression, alignment, stabilization, and image-guided surgical solutions, as well as a surgical navigation system used to facilitate fusion in degenerative, minimally invasive, and complex spinal deformity procedures throughout the lumbar, thoracic, and cervical regions of the spine. SeaSpine Holdings Corporation was incorporated in 2015 and is headquartered in Carlsbad, California.

Full SPNE Calculator →

YUMConsumer Discretionary

YUM! Brands, Inc., together with its subsidiaries, develops, operates, and franchises quick service restaurants worldwide. It operates through four segments: the KFC Division, the Taco Bell Division, the Pizza Hut Division, and the Habit Burger Grill Division. The company operates restaurants under the KFC, Pizza Hut, Taco Bell, and The Habit Burger Grill brands, which specialize in chicken, pizza, made-to-order chargrilled burgers, sandwiches, Mexican-style food categories, and other food products. As of December 31, 2021, it had 26,934 KFC units; 18,381 Pizza Hut units; 7,791 Taco Bell units; and 318 The Habit Burger Grill units in approximately 157 countries and territories. The company was formerly known as TRICON Global Restaurants, Inc. and changed its name to YUM! Brands, Inc. in May 2002. YUM! Brands, Inc. was incorporated in 1997 and is headquartered in Louisville, Kentucky.

Full YUM Calculator →
📬

Get this SPNE vs YUM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SPNE vs SCHDSPNE vs JEPISPNE vs OSPNE vs KOSPNE vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.